The formation of inositol phosphates in response to agonists was studied in brain slices, parotid gland fragments and in the insect salivary gland. The tissues were first incubated with [3Hlinositol, which was incorporated into the phosphoinositides. All the tissues were found to contain glycerophosphoinositol, inositol 1-phosphate, inositol 1,4-bisphosphate and inositol 1,4,5-trisphosphate, which were identified by using anionexchange and high-resolution anion-exchange chromatography, high-voltage paper ionophoresis and paper chromatography. There was no evidence for the existence of inositol 1: 2-cyclic phosphate. A simple anion-exchange chromatographic method was developed for separating these inositol phosphates for quantitative analysis. Stimulation caused no change in the levels of glycerophosphoinositol in any of the tissues. The most prominent change concerned inositol 1,4-bisphosphate, which increased enormously in the insect salivary gland and parotid gland after stimulation with 5-hydroxytryptamine and carbachol respectively. Carbachol also induced a large increase in the level of inositol 1,4,5-trisphosphate in the parotid. Stimulation of brain slices with carbachol induced modest increase in the bis-and tris-phosphate. In all the tissues studied, there was a significant agonist-dependent increase in the level of inositol 1-phosphate. The latter may be derived from inositol 1,4-bisphosphate, because homogenates of the insect salivary gland contain a bisphosphatase in addition to a trisphosphatase. These results suggest that the earliest event in the stimulus-response pathway is the hydrolysis of polyphosphoinositides by a phosphodiesterase to yield inositol 1,4,5-trisphosphate and inositol 1,4-bisphosphate, which are subsequently hydrolysed to inositol 1-phosphate and inositol. The absence of inositol 1:2-cyclic phosphate could indicate that, at very short times after stimulation, phosphatidylinositol is not catabolized by its specific phosphodiesterase, or that any cyclic derivative liberated is rapidly hydrolysed by inositol 1: 2-cyclic phosphate 2-phosphohydrolase.
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Agonists that interact with receptors to produce a calcium signal are also able to induce the hydrolysis of phosphoinositides. The relationship between calcium signalling and phospholipid metabolism remains very much a controversial issue, mainly because we have relatively little information on the Abbreviations used: Ptdlns, phosphatidylinositol; PtdIns4P, phosphatidylinositol 4-phosphate; Ptdlns-(4,5)P2, phosphatidylinositol 4,5-bisphosphate; Ins 1 P, myo-inositol 1-phosphate; Ins(1,4)P2, myo-inositol 1,4-bisphosphate; Ins(1,4,5)P3, inositol 1,4,5-triphosphate.
Vol. 212 precise mechanism whereby agonists hydrolyse these inositol-containing phospholipids. It has been documented that a number of agonists acting on many different cell types can induce the disappearance of PtdIns (Michell, 1975 (Michell, , 1979 Berridge, 1980 Berridge, , 1981 Putney, 1981; Irvine et al., 1982) .
However, there is also substantial evidence to show that many of these same agonists can also stimulate the disappearance of the polyphosphoinositides represented by PtdIns4P and Ptdlns(4,5)P2 (Durell et al., 1968; Abdel-Latif et al., 1977; Griffin & Hawthorne, 1978; Akhtar & Abdel-Latif, 1980; Weiss et al., 1982) . 
Incubation of parotid gland fragments and brain slices
The dissection and preparation of rat parotid gland fragments and cerebral cortical slices have been described previously (Hanley et al. 1980; Berridge et al., 1982) . Experiments on both tissues were essentially identical, except that the medium used for parotid gland incubations was a modified Krebs-Ringer bicarbonate containing 10mM-inosine, 0.4 mM-adenosine and 5 mM-3-hydroxybutyrate. The 1, 4, phate at 300C for 5 or 15min. Assays were stopped by addition of an equal volume of 15% (w/v) trichloroacetic acid and the precipitated proteins were removed by centrifugation. In the control, trichloroacetic acid was added to a portion of the gland homogenate before the addition of substrate. Trichloroacetic acid was removed from the supernatant by five extractions with diethyl ether, and the extract was neutralized with 6.25 mM-sodium tetraborate before being applied to Dowex-1 columns.
Extraction ofwater-soluble metabolites Two different methods were used to extract the water-soluble metabolites. In those cases where the incubations were stopped by the addition of chloroform/methanol, the fluid was transferred to a test tube and the remaining tissue was then homogenized in 200,1 of 0.5 M-HCI. In two separate experiments we replaced the 0.5 M-HCI with distilled water so that the acid-labile inositol 1: 2-cyclic phosphate could be quantitatively extracted. The homogenate was added to the chloroform/methanol extract, as was a further 200,1 of water, which was used to wash out the homogenizer. After addition of 200,1 of chloroform the tubes were centrifuged. After collecting the upper phase the interface was washed twice with 200,u1 of an upper phase prepared from chloroform/methanol/0. 1 M-sodium cyclohexane-1,2-diaminetetra-acetic acid (16:8:5, by vol.) . This combined upper phase and washing was then dried and stored at -150C. This extract was dissolved in 1 ml of 6.25 mM-sodium tetraborate before being applied to the anion-exchange columns.
In those experiments where the incubation was stopped by the addition of ice-cold 15% trichloroacetic acid, the samples were left on ice for 15 min. The tubes were centrifuged and the extract was removed and washed five times with diethyl ether. The extract was then neutralized before being applied to the anion-exchange columns.
Separation of water-soluble metabolites by anionexchange chromatography
The water-soluble extracts were applied to columns containing 1 ml of Dowex-l (X8; formate form; Sigma Chemical Co., London S.W.6, U.K.). The phosphate esters were eluted by the stepwise addition of solutions containing increasing levels of formate as described by Richards et al. (1979) and by . Details of the solutions used are provided in the legend to Fig. 1 . A 0.5 ml portion of each fraction was taken for liquid-scintillation counting or for total phosphorus determination by the method of Bartlett (1959) .
Separation of water-soluble metabolites by highvoltage ionophoresis andpaper chromatography
The method used was similar to that described by Dawson & Clarke (1972) . For all experiments, the entire paper was cut into 1 cm strips and counted for radioactivity by scintillation counting, to ensure both a complete recovery of radioactivity and the detection of all radioactive compounds. Ins(l,4)P2 was also identified by paper chromatography in n-propanol/conc. NH3/water (5:4: 1, by vol.) as described by Grado & Ballou (1961) . Generally, the chromatography was for 48 h to ensure a large movement (>20 cm) of Ins(1,4)P2. Preparation ofstandards Glycerophosphoinositol and inositol 1 :2-cyclic phosphate were prepared as described by Dawson & Clarke (1972) . InsiP was prepared by the hydrolysis of PtdIns by a brain supernatant. Inositol bisphosphate and inositol trisphosphate of unknown positional isomerism were prepared by acid hydrolysis of PtdIns4P and PtdIns(4,5)P2 respectively, followed by paper-ionophoretic separation. Also, 32P-labelled Ins(1,4)P2 and Ins(1,4,5)P3 were prepared enzymically, either directly from 32P-labelled erythrocyte ghosts as described by , or by treating the corresponding radioactive phosphoinositide with a rat brain supernatant.
Results
Identification of water-soluble inositol metabolites in blowfly salivary gland
The water-soluble extract obtained from control or 5-hydroxytryptamine-stimulated blowfly salivary glands contained five distinct 3H-containing peaks when run through an anion-exchange column ( Fig.   1 ). 5-Hydroxytryptamine caused large increases in peaks I, III and IV, with no change in peak II and a small increase in peak V. Five major radioactive spots were also identified when similar extracts were separated by high-voltage ionophoresis. On the basis of previous studies (Dawson & Clarke, 1972) these spots corresponded to inositol, glycerophosphoinositol, InsIP, Ins(1,4)P2 and Ins(1,4,5)P3. This identification of metabolites by ionophoresis was substantiated by using anion-exchange columns to compare the behaviour of standards with the unknown peaks shown in Fig. 1 . For this identification procedure, a large extract was prepared so that similar portions could be compared with the different standards. This procedure provided a way of establishing whether the existence of large amounts of the standard altered the behaviour of the labelled metabolite that exists in trace amounts.
Peak I was established as myo-inositol on the basis that it was not retained on the column and that this first peak had a profile identical with that of standard [3Hlinositol. Furthermore, ionophoretic experiments revealed that the gland extract contained an uncharged molecule whose mobility was identical with standard inositol.
Peak II was identified as glycerophosphoinositol ( Fig. 2a) . The radioactivity obtained from the gland coincided exactly with standard glycerophosphoinositol. In a separate experiment, a cell extract together with standard glycerophosphoinositol were separated by ionophoresis. The spot corresponding to this substance was then cut out, eluted from the paper and re-run through the anion-exchange column. The result was similar to that shown in Fig.  2 (a), suggesting that peak II is glycerophosphoinositol. The eluted spot also cochromatographed exactly with glycerophosphoinositol when run on paper in propanol/ NH3 (Dawson & Clarke, 1972) . After digestion with 6M-HCI at 100°C for 18h, all the radioactivity was found to be in a spot corresponding to inositol after chromatography in n-propanol/ethyl acetate/water (24: 13:7, by vol.).
Vol. 212 Peak III has already been identified as InslP in a previous study (Berridge et al., 1982) . Further confirmation is provided in Fig. 2(b) , where standard InslP was eluted at the same position as the radioactive metabolite obtained from the salivary glands. A similar correspondence was observed on both ionophoresis and chromatography in propanol/ NH3.
Peak IV was eluted at the same position as standard inositol 1,[32P]4-bisphosphate (Fig. 2c ). This peak was also compared with standard inositol bisphosphate prepared by acid hydrolysis of PtdIns4P. A cell extract to which standard inositol bisphosphate had been added was firstly separated by paper ionophoresis. One of the unknown radioactive metabolites ran in exactly the same position as the standard inositol bisphosphate. When this spot was eluted and re-run through the anion-exchange columns the radioactivity was eluted in exactly the same position as the standard, again indicating the existence of inositol bisphosphate. When the radioactivity obtained from peak IV was hydrolysed for 18h at 1000C in 6M-HC1, all the radioactivity was recovered in inositol after separation by paper chromatography in n-propanol/ ethyl acetate/water (24:13:7, by vol.). The compound in peak IV did not exactly co-chromatograph with the inositol bisphosphate prepared by acid hydrolysis of PtdIns4P, when they were run on paper chromatograms in n-propanol/saturated NH3/ water (5:4:1, by vol.) as described by Grado & Ballou (1961) . However, such acid hydrolysis randomizes the phosphate groups on the inositol ring, and Grado and Ballou's solvent will separate the different isomers of inositol bisphosphate from one another. That this is so was confirmed in two ways. If peak IV was submitted to 20min hydrolysis in 1 M-HCI at 1000C, it then chromatographed faster and corresponded to the standard inositol bisphosphate prepared by acid hydrolysis. Secondly, enzymically prepared 32P-labelled Ins(1,4)P2, when chromatographed in Grado and Ballou's solvent, was found by autoradiography to co-chromatograph exactly with the [3Hlinositol-labelled compound from salivary gland, identifying the latter as Ins( 1,4)P2.
Peak V corresponds to standard Ins( 1,4,5)P3. This peak was found to coincide exactly both on anion-exchange columns (Fig. 2d) and by ionophoresis with a 32P-labelled Ins(1,4,5)P3 standard prepared by hydrolysing 32P-labelled PtdIns(4,5)P2 in erythrocyte membranes .
In summary, a combination of high-voltage ionophoresis, paper chromatography and anionexchange chromatography has established that the peaks in Fig. 1 are inositol (peak I), glycerophosphoinositol (peak II), InsiP (peak III), Ins(1,4)P2 (peak IV) and Ins(1,4,5)P3 (peak V). Identification of water-soluble inositol metabolites in extractsfrom rat parotid gland and brain slices When extracts obtained from control or Groups of five salivary glands were labelled, stimulated with lOpM-5-hydroxytryptamine for 90s and extracted as described in the legend to Fig. 1 . Standards (@) were added to the tissue extracts and run through anion-exchange columns using the solutions described in the legend to Fig. 1 A water-soluble extract of these glands was used to test the recovery of metabolites from cell extracts. For the experimental set, groups of six unlabelled glands in 2004u of medium were treated with 1 ml of chloroform/methanol. A portion of the 3H-labelled cell extract was added to these glands, which were then taken through the usual acid-extraction procedure. For the controls, a portion of the 3H-labelled cell extract was taken through the same procedure but without any unlabelled glands. chloroform/methanol extracts of these tissues were prepared and then subjected to high-voltage ionophoresis we found no evidence for the presence of inositol 1: 2-cyclic phosphate.
Efficiency of the procedure for extracting metabolitesfrom tissues As a prelude to a quantitative analysis of how these water-soluble metabolites vary during the action of agonists, tests were carried out on the efficiency of the extraction procedure. A bulk extraction containing 3H-labelled inositol metabolites was prepared from the blowfly salivary gland and portions were added to unlabelled glands and taken through the normal extraction procedure. Similar portions taken through the same procedure but in the absence of unlabelled glands served as controls. All the metabolites were recovered completely apart from a small reduction in the level of Ins lP (Table   1) .
Changes in the level of inositol and inositol phosphates during stimulation of the blowfly salivary gland with S-hydroxytryptamine As shown in Fig. 1 , 5-hydroxytryptamine induced large increases in the levels of radioactivity appearing in inositol (peak I), Ins 1P (peak III) and Ins(1,4)P2 (peak IV). A quantitative analysis of these changes is presented in Table 2 . The samples obtained from control and stimulated glands were analysed by both anion-exchange chromatography and paper ionophoresis. Both techniques revealed (Hanley et al., 1980 ). This enhanced labelling was prevented if the pre-labelled glands were first extensively washed in a medium containing 10mM unlabelled inositol as described in the Materials and methods section (results not shown). However, if the time of the incubation with the unlabelled inositol was reduced from 60 min to 30 min, then a small PtdIns-labelling response to carbachol still occurred.
Separation of 3H-labelled metabolites on Dowex-1 (formate) columns was the most convenient chromatographic technique for routine quantitative analysis. The results of such separations of the components in extracts from parotid gland slices that had been stimulated with the Ca2+-mobilizing agonists carbachol (acting at muscarinic receptors), phenylephrine and Substance P are shown in Table  3 . After 10 min exposure to carbachol (1 mM), there were large increases in the levels of radioactivity found in the peaks corresponding to Ins 1P, Ins(1,4)P2 and Ins(1,4,5)P3. The biggest change was found in the Ins(1,4)P2 fraction, which increased about 44-fold. There was only a modest increase in the glycerophosphoinositol fraction and the apparent increase in the level of [3Hlinositol was not significantly different from the control. All of the changes were blocked by 10#uM-atropine.
The effects of phenylephrine and Substance P were quantitatively much smaller, but qualitatively similar to those of carbachol. Once again the most prominent increase, with both those agonists, was in the Ins(1,4)P2 fraction, with significant rises in the levels of InslP and the trisphosphate. We could not detect a change in the levels of glycerophosphoinositol or free inositol.
Homogenates of parotid gland, like the blowfly salivary gland (see below), rapidly hydrolysed 32P-labelled Ins( 1,4,5)P3 (results not shown).
Therefore these results are most easily reconciled with the notion that each of the Ca2+-mobilizing agonists stimulates a polyphosphoinositide phosphodiesterase that generates Ins( 1,4,5)P3 and/or Ins( 1,4)P2. Ins 1 P could then arise by stepwise hydrolysis of the polyphosphates as described for the blowfly. The results do not entirely preclude the possibility that some InsiP might be formed directly from Ptdlns. Changes in the levels of 3H-labelled metabolites during stimulation ofrat brain slices with carbachol Table 4 shows that carbachol induced modest increases in the levels of Ins(1,4)P2 and the inositol Vol. 212 trisphosphate. In the experiment shown we did not detect a significant increase in Ins IP but this compound tended to accumulate with time and it usually rose significantly when the incubation time was increased to 30 min (results not shown).
Although the results for brain slices are not so startling as those for the mammalian salivary glands, they do suggest that a similar, if not identical, enzyme mechanism underlies the action of muscarinic agonists in the rat and of 5-hydroxytryptamine in the blowfly.
Inositol 1,4-bisphosphatase and inositol 1,4,5-trisphosphatase activity in insect salivary gland A homogenate of the insect salivary gland was able to degrade inositol 1,4,5-[4,5-32Pltrisphosphate to inositol 1,[32P]4-bisphosphate (Fig 3) . (Hallcher & Sherman, 1980) , we conclude that the inositol 1,4-bisphosphatase removes phosphate specifically from the 4-position on the inositol ring. InsIP would not be detected in our elution profiles since the substrate was prepared from red blood cells and thus carries [32Plphosphate at the 4-and 5-positions but not at the 1-position (Michell, 1975 (Michell, , 1979 Berridge, 1980 Berridge, , 1981 Putney, 1981; Irvine et al., 1982) . When such agonists interact with the appropriate receptor, there is a rapid disappearance of these phosphoinositides. Although most attention has been focused on PtdIns, there is now considerable evidence to show that there is also a rapid removal of the polyphosphoinositides . Indeed, the latter are broken down considerably faster than Ptdlns when liver cells are stimulated with vasopressin . Although it has been clearly established that agonists can stimulate the breakdown of all the phosphoinositides, the precise biochemical pathways responsible for this reduction in lipid level are not clear. Since all these phosphoinositides are readily interconvertible, there are a number of ways whereby an agonist could induce such a breakdown of all three forms. For example, a reduction in the level of PtdIns could occur through an increase in its phosphorylation to PtdIns4P or, as seems more likely, an increase in its hydrolysis by a phosphodiesterase. Likewise, the polyphosphoinositides could decline either by being dephosphorylated back to Ptdlns by means of phosphomonoesterases or by being hydrolysed by a phosphodiesterase. It is not possible, therefore, to determine which pathway is being used simply by studying the rate at which these phospholipids are being degraded.
Another approach is to study the water-soluble products that are released when these phosphoinositides are hydrolysed by the relevent phosphodiesterases. The water-soluble products are sufficiently unique as to provide a chemical signature that should identify which phosphoinositide is the primary substrate for the receptor mechanism. For example, the hydrolysis of PtdIns by its phosphodiesterase yields a mixture of inositol 1:2-cyclic phosphate and Ins IP; PtdIns4P gives Ins(1,4)P2; and Ptdlns(4,5)P2 will produce Ins(1,4,5)P3. The existence of such inositol phosphates was first described by Durell et al. (1968) , who showed that a crude mitochondrial fraction of brain contained InsMP, Ins(1,4)P2 and traces of the trisphosphate. Acetylcholine stimulated a small increase in the levels of InsIP and Ins(1,4)P2. An increase in these two inositol phosphates has also been described in guinea-pig synaptosomes after treatment with ionophore A23 187 (Griffin & Hawthorne, 1978) . A slightly different pattern was described in rabbit iris smooth muscle, where acetylcholine stimulated an increase in the release of Ins IP and Ins(1,4,5)P3 with no change in the level of the bisphosphate (Akhtar & Abdel-Latif, 1980) . In the present study on brain and on insect and mammalian salivary gland, we have identified four major inositol phosphates [glycerophosphoinositol, Ins IP, Ins(1,4)P2 and Ins(1,4,5)P31. In a previous study on the insect salivary gland, Fain & Berridge (1979) , by using a paper-chromatographic separation technique, reported the existence of glycerophosphoinositol, Ins IP and inositol 1: 2-cyclic phosphate. The presence of the cyclic phosphate is of particular significance because its existence would suggest that Ptdlns was being degraded by its specific phosphodiesterase as part of the receptor mechanism. However, the more sophisticated separation techniques described in the present paper have failed to detect any inositol 1 :2-cyclic phosphate, but instead have detected the existence of Ins(1,4)P2 and Ins(1,4,5)P3. It seems likely that the radioactive material previously identified by Fain & Berridge (1979) as inositol 1:2-cyclic phosphate may have been contaminated with Ins(1,4)P2. The identification of these various products has been verified by using a variety of separation techniques and a routine procedure has been developed for measuring these inositol phosphates in tissue extracts.
A characteristic feature of the responsiveness of the insect salivary gland and mammalian parotid gland to agonists was the very large increase in the inositol phosphates derived from the polyphosphoinositides. In the insect salivary gland, there was a 10-fold increase in the level of Ins(1,4)P2 after stimulation with 5-hydroxytryptamine for 1 min. Agonists such as carbachol induced very large increases in the levels of Ins(1,4)P2 and Ins(1,4,5)P3 in the parotid. Such large increases in the levels of these two inositol phosphates would seem to suggest that one of the primary biochemical actions of the agonist is to stimulate the hydrolysis of the polyphosphoinositides by a phosphodiesterase. A previous study on the parotid has already described a large decrease in the level of 32P-labelled Ptdlns(4,5)P2 upon stimulation with methacholine, Substance P or adrenaline (Weiss et al., 1982 ). An increase in the appearance of Ins(1,4,5)P3 is thus consistent with the idea that the agonist is acting to stimulate the hydrolysis of a polyphosphoinositide through a phosphodiesterase rather than through a phosphomonoesterase pathway. However, the picture is complicated by the fact that these agonists also increased the level of InslP and free [3HI-inositol, which is presumably produced from InsIP by phosphomonoesterase action. This InsIP could be formed directly by the breakdown of Ptdlns or it might arise from the action of phosphomonoesterase on the Ins(1,4)P2 and In(1,4,5)P3. Although the failure to detect inositol 1 : 2-cyclic phosphate could suggest that the latter pathway operates, it is known that many tissues contain an active inositol 1: 2-cyclic phosphate 2-phosphohydrolase (Dawson & Clarke, 1972) , which could rapidly convert the cyclic derivative into Ins 1P.
Not much is known about the phosphomonoesterases that carry out the stepwise dephosphorylation of Ins(1,4,5)P3 to inositol. The first enzyme in the sequence, an Ins(1,4,5)P3 phosphomonoesterase, has been characterized in red cell membranes . A characteristic feature of this enzyme is that it specifically removes the phosphate at the 5-position to yield Ins(1,4)P2. A crude homogenate of the insect salivary gland was capable of removing phosphate from the 4-and 5-positions to yield Ins iP. Since there was no accumulation of Ins4P, it seems likely that the bisphosphatase is specific for the phosphate carried on the 4-position of the inositol ring. The final step in this pathway is the conversion of InslP into free inositol by the inositol I-phosphatase. Inhibition of this enzyme by Li+ leads to very large accumulations of Ins IP in a number of tissues (Berridge et al., 1982) . These phosphomonoesterases are thus quite specific in that the trisphosphatase removes the 5-phosphate, the bisphosphatase removes the 4-phosphate, and the last enzyme in the sequence removes phosphate from the 1-position.
An interesting feature of these enzyme studies was that the inositol trisphosphatase that removed the phosphate at the 5-position appeared to be somewhat more active than the bisphosphatase that removes the phosphate from the 4-position. If this difference in enzyme activity also occurs in vivo, it would explain why stimulation of the insect gland with 5-hydroxytryptamine induced a large accumulation of Ins(1,4)P2 with little change in the level of Ins(1,4,5)P3, which is presumably rapidly degraded. When the insect salivary gland was stimulated with 5-hydroxytryptamine over time periods of less than 1 min, there was a transient increase in the level of Ins(1,4,5)P3 (M. J. Berridge, unpublished work).
The large accumulations of Ins(1,4)P2 and Ins(1,4,5)P3 thus indicate that agonists may act by initiating the hydrolysis of the polyphosphoinositides through a specific phosphodiesterase. These inositol phosphates are then dephosphorylated to inositol through a series of phosphomonoesterases. Such a mechanism implies that the agonist-dependent decline in the level of PtdIns that has previously been described in many tissues could arise indirectly, as this lipid is phosphorylated to replace the polyphosphoinositides being consumed by the receptor mechanism. In other words, PtdIns would be removed through the action of a kinase rather than through a phosphodiesterase. On the basis of this model, the increase in Ins IP is the result of a bisphosphatase acting on the Ins(1,4)P2 arising from the polyphosphoinositides. However, the data in the present paper cannot preclude the possibility that some Ins IP may be derived from direct action on Ptdlns of its specific phosphodiesterase, which exists in high concentrations in all tissues so far examined. A kinetic analysis of the early changes that occur in these inositol phosphates upon stimulation will be required to throw more light on Vol. 212 which of these phosphoinositides is the primary substrate for the receptor mechanism.
